Common Commands

Usage Examples

The following example creates a Frame Relay endpoint and binds it to the t1 1/1 physical interface:

1. Create the Frame Relay virtual endpoint and set the signaling method:

(config)#interface frame-relay 1 (config-fr1)#frame-relay lmi-type cisco

2. Create the sub-interface and configure the PVC parameters (including DLCI and IP address):

(config-fr 1)#interface fr 1.1

(config-fr1.1)#frame-relay interface-dlci 17

(config-fr 1.1)#ip address 168.125.33.252 255.255.255.252

3. Create the tdm-group of 12 DS0s (64K) on the t1 physical interface:

(config)#interface t1 1/1

(config-t11/1)#tdm-group 1 timeslots 1-12 speed 64 (config-t1 1/1)#exit

4.Connect the Frame Relay sub-interface with port t1 1/1: (config)#bind 1 t1 1/1 1 fr 1

Technology Review

Creating an endpoint that uses a layer 2 protocol (such as Frame Relay) is generally a four-step process:

Step 1:

Create the Frame Relay virtual endpoint (using the interface frame-relaycommand) and set the signaling method (using the frame-relaylmi-typecommand). Also included in the Frame Relay virtual endpoint are all the applicable Frame Relay timers logging thresholds, encapsulation types, etc. Generally, most Frame Relay virtual interface parameters should be left at their default state. For example, the following creates a Frame Relay interface labeled 7 and sets the signaling method to ansi.

(config)#interface frame-relay 7 (config-fr7)#frame-relay lmi-type ansi

Step 2:

Create the sub-interface and configure the PVC parameters. Using the sub-interface , apply access policies to the interface, create bridging interfaces, configure backup, assign an IP address, and set the PVC data-link control identifier (DLCI). For example, the following creates a Frame Relay sub-interface labeled 22, sets the DLCI to 30, and assigns an IP address of 193.44.69.253 to the interface.

5991-2114

© Copyright 2005 Hewlett-Packard Development Company, L.P.

925

Page 925
Image 925
HP 7000 dl Router manual Copyright 2005 Hewlett-Packard Development Company, L.P 925